V114 + QIV + Matching Placebo for V114
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Pneumococcal Infections
Conditions
Pneumococcal Infections
Trial Timeline
Sep 14, 2018 → Jun 24, 2019
NCT ID
NCT03615482About V114 + QIV + Matching Placebo for V114
V114 + QIV + Matching Placebo for V114 is a phase 3 stage product being developed by Merck for Pneumococcal Infections. The current trial status is completed. This product is registered under clinical trial identifier NCT03615482. Target conditions include Pneumococcal Infections.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03615482 | Phase 3 | Completed |
Competing Products
20 competing products in Pneumococcal Infections